Details for New Drug Application (NDA): 212718
✉ Email this page to a colleague
The generic ingredient in ACYCLOVIR is acyclovir sodium. There are fifty-six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the acyclovir sodium profile page.
Summary for 212718
Tradename: | ACYCLOVIR |
Applicant: | Chartwell Rx |
Ingredient: | acyclovir |
Patents: | 0 |
Pharmacology for NDA: 212718
Mechanism of Action | DNA Polymerase Inhibitors |
Medical Subject Heading (MeSH) Categories for 212718
Suppliers and Packaging for NDA: 212718
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ACYCLOVIR | acyclovir | SUSPENSION;ORAL | 212718 | ANDA | Chartwell RX, LLC | 62135-803 | 62135-803-47 | 473 mL in 1 BOTTLE (62135-803-47) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 200MG/5ML | ||||
Approval Date: | Apr 23, 2020 | TE: | AB | RLD: | No |
Complete Access Available with Subscription